ESG

Thorne released impressive consumer data for its supplements. But what do these studies really mean for consumers in a crowded, unregulated market?

A Florida golf company is merging to form a U.S. drone firm backed by Eric and Donald Trump Jr., aiming to dominate the defense technology market.

The iconic distillery's latest limited release honors its operations teams, blending innovative wood finishing with a story of human craftsmanship.

A new surgical robot from Beijing's Healinno Tech uses AI and a high-pressure waterjet to treat prostate issues with unprecedented precision and safety.

The Braille Challenge arrives in Kenya, its first African location, aiming to boost literacy for thousands of visually impaired students facing a resource gap.

Healthcare tech firm Marpai secures a massive marketing deal, gaining potential access to 1.5 million employees for its transparent pharmacy benefit platform.

A year after rebranding from FibroGen, Kyntra Bio's first full-year report will test if its lean strategy can fuel its ambitious oncology pipeline.

A new survey reveals firms are rushing to deploy AI without proper data management, accumulating a costly and dangerous 'technical debt' that threatens innovation.

A new non-thermal ablation technology shows long-term success in shrinking thyroid nodules with high patient satisfaction, potentially disrupting surgical norms.

With one trial halted and another beginning, the company focuses its cash and hopes on BBI-940, a novel drug targeting a fundamental driver of cancer.

A new AI-designed drug shows promise in selectively burning fat while preserving muscle, with a potential twice-yearly dosing schedule for obesity.

A Vietnamese company has launched a new infant formula with IgHM, an ingredient designed to replicate the immune antibodies found in human breast milk.

Canada Nickel secures a critical power deal with Hydro One, a major step for its net-zero nickel mine, built on a foundation of Indigenous partnership.

UK's Abselion opens a US base in Cambridge, MA, aiming to disrupt biologics R&D with its rapid Amperia protein quantification system.

IDEAYA Biosciences begins a key trial for its targeted therapy IDE892, aiming to conquer hard-to-treat tumors and pivoting to focus on its proprietary assets.

Hong Kong's OP Investment Management reports record 2025 growth, riding historic rallies in China and Korea to solidify its role as a key platform.

Moving to FAST platforms, Mind-Sync TV pioneers 'Functional TV,' a new category of 4K content designed to enhance focus, not just entertain.

With its runway extended by insiders, the biotech firm bets on its promising glioblastoma drug and an unconventional strategy of crypto and acquisitions.

With new federal funding and key milestones met, E3 Lithium's DLE technology is set to unlock vast lithium resources from Alberta's oil brines.

Beijing is pouring trillions into AI, 6G, and biomanufacturing to dominate the next tech era, offering Europe partnership amidst rising competition.